Xuelin (Steve) Wang

We advised Zhenro Properties on the Regulation S offering

We advised the initial purchasers on the Regulation S senior notes offering

Davis Polk advised Antengene Corporation Limited in connection with its initial public offering and listing on the Hong Kong Stock Exchange and an international offering in reliance on Rule…

Davis Polk advised the underwriters in the initial public offering of RemeGen Co., Ltd. on the Hong Kong Stock Exchange and an international offering and listing in reliance on Rule 144A…

Davis Polk advised the underwriters in the initial public offering of JW (Cayman) Therapeutics Co. Ltd on the Hong Kong Stock Exchange and an international offering and listing in reliance…

Davis Polk advised Zai Lab Limited in connection with its secondary listing and initial public offering on the Hong Kong Stock Exchange. Zai Lab is the first company listed under both…

Davis Polk advised the initial purchasers in connection with a Regulation S offering by Zhenro Properties Group Limited of $350 million 7.350% senior notes due 2025. Zhenro Properties Group…

Davis Polk advised the joint lead managers in connection with a $500 million Regulation S bonds offering by Shui On Development (Holding) Limited of its 6.150% senior notes due 2024…

Davis Polk advised the initial purchasers in connection with a $200 million Regulation S high-yield offering by KWG Group Holdings Limited of its 5.950% senior notes due 2025. KWG Group…

Davis Polk advised the sole placing agent for the placement of 56,200,000 new shares and 36,800,000 existing shares in Innovent Biologics, Inc., for an aggregate consideration of…